Citric Acid → 1-butyl-N,N-dimethyl-4,4-bis(3-methyl-5-(trifluoromethyl)-1H-indol-2-yl)cyclohexanamine 2-hydroxypropane-1,2,3-tricarboxylate

HRID 1011622Notizen

Reaktionsgleichung

Reaktionsgleichung von HRID 1011622
[CH2:1]([C:5]1([N:39]([CH3:41])[CH3:40])[CH2:10][CH2:9][C:8]([C:25]2[NH:26][C:27]3[C:32]([C:33]=2[CH3:34])=[CH:31][C:30]([C:35]([F:38])([F:37])[F:36])=[CH:29][CH:28]=3)([C:11]2[NH:12][C:13]3[C:18]([C:19]=2[CH3:20])=[CH:17][C:16]([C:21]([F:24])([F:23])[F:22])=[CH:15][CH:14]=3)[CH2:7][CH2:6]1)[CH2:2][CH2:3][CH3:4].[C:42]([OH:54])(=[O:53])[CH2:43][C:44]([CH2:49][C:50]([OH:52])=[O:51])([C:46]([OH:48])=[O:47])[OH:45]>C(O)C>[OH:45][C:44]([C:46]([OH:48])=[O:47])([CH2:49][C:50]([OH:52])=[O:51])[CH2:43][C:42]([OH:54])=[O:53].[CH2:1]([C:5]1([N:39]([CH3:41])[CH3:40])[CH2:10][CH2:9][C:8]([C:11]2[NH:12][C:13]3[C:18]([C:19]=2[CH3:20])=[CH:17][C:16]([C:21]([F:22])([F:24])[F:23])=[CH:15][CH:14]=3)([C:25]2[NH:26][C:27]3[C:32]([C:33]=2[CH3:34])=[CH:31][C:30]([C:35]([F:38])([F:36])[F:37])=[CH:29][CH:28]=3)[CH2:7][CH2:6]1)[CH2:2][CH2:3][CH3:4]

Komponenten

4

Versuchsvorschrift

1-butyl-N,N-dimethyl-4,4-bis(3-methyl-5-(trifluoromethyl)-1H-indol-2-yl)cyclohexanamine (100 mg, 0.17 mmol) was dissolved in ethanol (10 ml) and mixed with citric acid (36 mg, 0.187 mmol) dissolved in hot ethanol (3 ml). The clear colourless solution was stirred for 48 h and then concentrated to low volume. After adding diethyl ether (10 ml), the mixture was stirred for 2 h at RT and the precipitate was then aspirated.

Aufarbeitung

  1. concentrationconcentrated to low volume
  2. additionAfter adding diethyl ether (10 ml)
  3. stirringthe mixture was stirred for 2 h at RT

Quellen und Nachweise

ORD-Eintrag
ord-7dd5d2d7c7404608aa092da276995103
Quelldatensatz
uspto-grants-2011_07
Patentnummer
US07977370B2

Notizen zur Reaktion

Wird geladen…